India is known as the "Pharmacy of the World" for its low-cost generic medicines, but a quieter revolution is underway in a different category: biosimilars. These are near-copies of complex…
India's pharmaceutical sector is widely expected to miss its 2030 sales target, as a combination of US import tariffs on generic drugs and prolonged shipping disruptions weigh on export momentum.…
Semaglutide — the active ingredient in Novo Nordisk’s Ozempic (for type 2 diabetes) and Wegovy (for weight management) — has become one of the most in-demand medicines in the world.…
India's central drug regulator is betting on digital technology to speed up drug approvals and sharpen oversight. The Central Drugs Standard Control Organisation (CDSCO) has announced plans to launch the…